Immunisation against infectious disease / Joint Committee on Vaccination and Immunisation.

  • Great Britain. Joint Committee on Vaccination and Immunisation.
Date:
1988
Catalogue details

Licence: Open Government Licence

Credit: Immunisation against infectious disease / Joint Committee on Vaccination and Immunisation. Source: Wellcome Collection.

    125/132 (page 115)
    4. HBIG will NOT inhibit the antibody response when given at same time as HB vaccine. Supplies Central Public Health Laboratory Tel. 01 200 6868 (Hepatitis Epidemiology Unit) Public Health Laboratories Scotland: Blood Transfusion Service (see 13.8.3) If HBIG is ordered from sources other than the Hepatitis Epidemiology Unit, it should be reported to the HEU as soon as possible by whoever places the order. 19.3.3 Rabies specific immunoglobulin (HRIG) HRIG is used after exposure to rabies to provide rapid protection until rabies vaccine, which should be given at the same time, becomes effective. Details of treatment are given in Section 13. HRIG is available in 1ml ampoules containing 500 IU. Dose. 20 IU/kg body weight. Up to half the dose is infiltrated in and around the wound after thorough cleansing and the rest given by intramuscular injection. Supplies Central Public Health Laboratory, Tel. 01 200 6868 (Virus Reference Laboratory) 19.3.4 Anti-varicella-zoster immunoglobulin (ZIG) ZIG is available in 1.7ml ampoules containing 250mg for intramuscular injection and is recommended for the following: 1. Immunosuppressed and leukaemic contacts of chicken pox or herpes zoster. 2. Individuals with debilitating disease who are in contact with chicken pox or herpes zoster. 3. Neonates born 6 days or less after onset of maternal chicken pox. 4. Neonates whose mothers develop chicken pox after delivery. 5. Neonates in contact with chicken pox or zoster whose mothers have no history of chicken pox. 6. Pregnant contacts.